131I-rituximab for Relapsed or Refractory Follicular or Mantle Cell Lymphoma

Clinical trial NCT01678417 · UNKNOWN

Trial details

NCT number: NCT01678417
Sponsor: Korea Cancer Center Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Follicular Lymphoma or Mantle Cell Lymphoma

Start date: 2012-06-01
Primary completion: 2017-06-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.